There was a significantly higher risk of ischemic stroke among people on SGLT2is compared with GLP1-Ra users (HR 1.53, 95% CI 1.01–2.33, p = 0.044; IRR 1.52, 95% CI 1.02–2.27, p = 0.041). This evidence concerns the gene GLP1R and ischemic stroke.